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Abstract  
Thymic atrophy has been described as a consequence of infection by several pathogens 
and shown to be induced through diverse mechanisms. Using the mouse model of 
Mycobacterium avium infection we show here that the production of nitric oxide from 
IFN-activated macrophages plays a major role in mycobacterial infection-induced 
thymic atrophy. Our results show that disseminated infection with a highly virulent strain 
of M. avium, but not with a low virulence strain, led to a progressive thymic atrophy. 
Thymic involution was prevented in genetically manipulated mice unable to produce 
IFNor the inducible nitric oxide synthase. In addition, mice with a selective impairment 
of IFNsignaling in macrophages were similarly protected from infection-induced 
thymic atrophy. A slight increase in the concentration of corticosterone was found in 
mice infected with the highly virulent strain and thymocytes presented an increased 
susceptibility to dexamethasone-induced death during disseminated infection. The 
administration of an antagonist of glucocorticoid receptors partially reverted the 
infection-induced thymic atrophy. We observed a reduction in all thymocyte populations 
analyzed, including the earliest thymic precursors, suggesting a defect during thymic 
colonization by T cell precursors and/or during the differentiation of these cells in the 
bone-marrow in addition to local demise of thymic cells. Our data suggest a complex 
picture underlying thymic atrophy during infection by M. avium with the participation of 
locally produced nitric oxide, endogenous corticosteroid activity and reduced bone 
marrow seeding. 
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Introduction 
Several microorganisms have been shown to cause premature thymic involution 
(1). How much premature thymic dysfunction impacts on the immune system depends on 
factors like the age of the individual, the precise mechanisms that caused thymic atrophy, 
the consequent ability for thymic recovery after the resolution of the infection, and the 
concomitant existence or not of peripheral lymphocyte depletion (2). When thymic 
atrophy occurs in parallel with peripheral lymphopenia, the reconstitution of the immune 
system depends to a great extent on the ability of the thymus to recover its ability to 
generate new T cells as it has been extensively shown for AIDS patients (3-5). Since 
several mechanisms have been implicated in infection-induced thymic atrophy and their 
role varies depending on the microorganism causing infection, determining which 
pathways are responsible for thymic atrophy in distinct situations is essential to define 
strategies to prevent thymic atrophy and/or promote the recovery of thymic function once 
the infection is controlled. 
Even though the thymus undergoes physiologic atrophy with age, T cells are 
generated and incorporated into the peripheral T cell pool in adulthood, albeit at slower 
rate than in children (6-9). Thymectomy or thymic dysfunction in early life has been 
shown to cause premature aging of the immune system in humans (10), as well as 
enhanced autoimmunity in mice (11). Moreover, loss of thymic activity in adults has 
been shown to reduce oral tolerance (12) and to hamper the affinity maturation of 
antibodies (13). Loss of thymic T cell output in adults has more obvious consequences 
when peripheral lymphopenia occurs concomitantly as it is the case in AIDS patients 
(14). 
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Several mechanisms have been implicated in infection-induced thymic atrophy. A 
major role was attributed to corticosteroids due to their ability to cause thymocyte death 
(15-18). The increased production of the pro-inflammatory cytokines TNF (16) and IFN 
(19) has also been proposed. While this increased apoptosis of the thymocytes is one of 
the mechanisms leading to thymic atrophy, the increased export of immature T cells (20) 
and the disturbance of thymic epithelia (19) have also been suggested. 
 We have previously shown that infection of C57Bl/6 mice with a highly virulent 
strain of M. avium (strain ATCC 25291 SmT) induces profound peripheral T cell 
depletion and premature thymic atrophy (21, 22) and that M. avium is able to 
progressively infect the thymus (23, 24). Since IFN is a key molecule in peripheral 
lymphocyte loss we aimed at analyzing the role of this cytokine in mycobacterial 
infection-induced thymic atrophy. Moreover, IFN is known to cause the up-regulation of 
the inducible nitric oxide synthase (iNOS) in mycobacterial infection (25) and nitric 
oxide has been shown to synergize with corticosterone in the induction of apoptosis of 
thymocytes in in vitro experiments (26). Thus, we also aimed at determining if nitric 
oxide was leading to thymic atrophy during mycobacterial infection. IFN induced 
macrophage activation and the resulting increase in iNOS activity were identified as a 
major mechanism responsible for M. avium induced thymic involution. Moreover, we 
show that IFN-induced thymic atrophy synergized with corticosterone signaling. 
Interestingly, infection with a low virulence strain that also leads to iNOS up-regulation 
through IFN activation, did not lead to thymic atrophy suggesting that corticosterone up-
regulation is essential for infection-induced thymic atrophy. Finally we provide evidence 
that the earliest steps of T cell differentiation might also be compromised. 
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Materials and Methods 
Mice, infection and thymectomy 
C57Bl/6 wild type (WT) mice were purchased from Charles River laboratories 
(Barcelona, Spain). IFN-deficient C57Bl/6 (IFN-KO) mice were bred in our facilities 
from a breeding pair purchased from Jackson Laboratories (Bar Harbor, ME). Transgenic 
mice with a selective impairment in IFN signaling in macrophages (MIIG) (27) were 
bred at the IBMC from a breeding pair provided by the Cincinnati Children’s Hospital 
Medical Center and the University of Cincinnati College of Medicine (Cincinnati, Ohio, 
USA). iNOS-deficient C57BL/6 mice (iNOS KO) (28) were bred in our facilities after 
backcrossing the original strain (kindly provided by Drs J. Mudgett, J. D. MacMicking 
and C. Nathan, Cornell University, New York, NY, USA) onto a C57BL/6 background 
for seven generations. 
Eight-to-ten weeks-old female mice were infected i.v. with 10
6
 CFU of the highly 
virulent M. avium strain ATCC 25291 SmT (obtained from the American Type Culture 
Collection; Manassas,
 
VA) or the low virulence strain 2447 (provided by Dr. F. Portaels, 
Institute of Tropical Medicine, Antwerp, Belgium) through a lateral tail vein. Bacterial 
inocula were prepared as described previously (21). The bacterial load in the organs was 
determined as previously described (23). While no signs of distress were observed for the 
first two months upon infection, some animals showed signs of deterioration of body 
condition in a non-synchronous way. To avoid excessive and unnecessary suffering of 
animals, humane end-points were applied. Mice were sacrificed when reaching 25% 
weight loss. 
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Thymectomy or sham thymectomy surgical procedures were performed on anesthetized 
8-weeks-old mice 2 weeks prior to infection. The thymi were removed by aspiration 
through a supra-sternum incision.  
All animal experiments were performed in accordance with the recommendations of the 
European Convention for the Protection of Vertebrate Animals used for Experimental 
and Other Scientific Purposes (ETS 123) and 86/609/EEC Directive and Portuguese rules 
(DL 129/92). The animal experimental protocol was approved by the competent national 
authority Direcção Geral de Veterinária (DGVet). 
Cell preparation 
Spleens and thymi were collected and processed individually. Cell-suspensions were 
obtained by gentle mechanical dissociation in PBS containing 3% FCS. Red blood cells 
were lysed using a hemolytic solution (155 mM NH4Cl, 10 mM KHCO3, pH 7.2) for 4 
min at room temperature, and cells were resuspended in DMEM supplemented with 10% 
heat inactivated FCS, 10 mM HEPES, 1mM sodium pyruvate, 2 mM L-glutamine, 50 
g/ml streptomycin and 50 U/ml penicillin (all from Invitrogen Life Technologies). The 
number of viable cells was counted by trypan blue exclusion using a hemocytometer. 
Histology 
Thymi were fixed on paraformaldehyde (4% in PBS) and embedded in paraffin. Thymic 
sections (2-3 µm) were stained by the Ziehl-Neelsen technique. Slides were visualized 
using an epifluorescence microscope (BX61 microscope) and photographed with an 
Olympus DP70 camera. 
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Flow cytometry 
For the flow cytometry analysis of splenocytes 10
6
 cells were stained with FITC-
conjugated anti-CD4 (RM4-5) or anti-CD19 (6D5) and PE-conjugated anti-CD8 (53-6.7). 
Propidium iodide (PI, Sigma-Aldrich) was added at a final concentration of 1 µg/mL to 
allow the exclusion of dead cells. For thymocyte analysis 10
6
 thymic cells were labeled 
with distinct combinations of the following antibodies: FITC or APC-conjugated anti-
CD3 (145-2C11), PE-Cy5.5 or V450-conjugated anti-CD4 (RM4-5), PE or V500-
conjugated anti-CD8 (53-6.7), PerCP-Cy5.5-conjugated anti-CD24 (M1/69), APC-Cy7-
conjugated anti-CD25 (PC61), Pe-Cy7-conjugated anti-CD44 (IM7) and Pe-conjugated 
anti-c-Kit (2B8). For Lin the following antibodies were used conjugated with the same 
fluorochrome (FITC): anti-CD19 (6D5), anti-B220 (RA3-6B2), anti-CD11b (M1/70), 
anti-CD11c (N418), anti-NK1.1 (PK136), anti-Gr1 (RB6-8C5), anti-TER119 (TER119). 
All antibodies were purchased from BioLegend (San Diego, CA) except the V450-
conjugated anti-CD4 (RM4-5) and the V500-conjugated anti-CD8 (53-6.7) that were 
obtained from BD Biosciences. The acquisition of the spleen or thymus cell populations 
was performed on a FACSCalibur flow cytometer using CellQuest software (BD 
Biosciences); on a LSRII or on a FACSCantoII flow cytometer using BD FACSDiva 
software (BD Biosciences). Data were analyzed using FlowJo software (Tree Star, 
Ashland, OR). 
Blockage of glucocorticoid receptors 
Mifepristone (RU486; Sigma-Aldrich), a synthetic glucocorticoid receptor antagonist, 
was dissolved in sterile polyethylene glycol 400 (PEG 400, Sigma-Aldrich) at a 
concentration of 5 mg/ml. Treatment was initiated by daily subcutaneous injections of 
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either RU486 (25 mg/Kg; 0.1 ml volume) or an equivalent volume of PEG 400 (vehicle-
treated mice) 1 day prior to infection until day 12 post-infection. This dose was 
previously shown to be effective in the reversion of corticosterone dependent lymph node 
atrophy in stressed and influenza infected mice (29, 30). From day 13 to 74 post-
infection, mice were treated daily by i.p. injection with either RU486 (2.5 mg/Kg; 0.2 ml 
volume) or an equivalent volume of vehicle. The RU486 solution for i.p. injections was 
obtained by dissolving RU486 in DMSO (Sigma-Aldrich) at a concentration of 50 
mg/ml. This DMSO stock solution was diluted 1/10 with 1 M acetic acid just prior to use 
and then diluted again in PBS/BSA to a final concentration of 250 g/ml. 
Determination of serum corticosterone level 
To obtain the serum concentration of corticosterone at basal levels blood samples were 
obtained at 9 a.m. from a venous incision at the tip of the tail during a period not 
exceeding 2 min for each mouse, to avoid corticosterone sera level increase due to 
handling. Sera were collected and stored at -80 ºC until assayed for corticosterone by 
radioimmunoassay using a 
125
I RIA Kit (MP Biomedicals). Corticosterone levels were 
determined from a standard curve and expressed in ng/ml. 
Dexamethasone Sensitivity Test  
Control or infected mice were treated i.p. with dexamethasone (Oradexon, N. V. Organon 
Oss Holand) at 0.1, 1.0 and 4.0 mg/Kg or PBS (PBS-treated animals) 24 h before 
sacrifice. Mice were sacrificed at day 50 post-infection and organs were removed for 
analysis. Thymocyte suspensions were obtained and analyzed by flow cytometry as 
described above. 
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Statistical analysis 
Results were expressed as mean + standard deviation (SD). Statistical significance was 
calculated by using the two-tailed Student’s t test for data presented on figure 2 A and the 
One-way ANOVA on all the other figures. Values of p0.05 were considered statistically 
significant. 
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Results 
 
Severe thymic atrophy occurs in mice infected with the highly virulent (25291) but not 
with the low virulence M. avium strain (2447) 
We compared the fate of the thymus in WT mice intravenously infected with a low 
virulence strain of M. avium (strain 2447) with that in mice infected with the highly 
virulent strain of M. avium 25291. As shown in Figure 1 A-C, the size, weight and 
cellularity of thymi from mice infected with M. avium 2447 did not differ from those of 
non-infected animals up to 80 days post-infection (dpi). Infection with strain 25291 led to 
a progressive shrinking of the organ, accompanied by a drastic reduction of its weight 
and cellularity. Flow cytometry analysis of the major thymocyte populations revealed no 
differences in mice infected with the low virulence strain as compared with thymi from 
non-infected controls (Figure 1 D-F). Infection with the highly virulent strain led to 
changes in the relative proportions and total counts of double-negative (DN, CD4
-
CD8
-
), 
double positive (DP, CD4
+
CD8
+
) and single-positive (SP, CD4
+
CD8
- 
or CD4
-
CD8
+
) 
populations. Thymic involution was somehow asynchronous with some mice exhibiting 
initial signs of thymic dysfunction sooner than others, as revealed by some variability in 
the pattern of thymocyte flow cytometry 60 dpi, illustrated in Figure 1D. On average, the 
cells exhibiting a greater relative depletion were the DP populations (Figure 1E) although 
all populations underwent massive loss from day 60 up to day 80 post-infection (Figure 
1F). This thymic atrophy was associated with increased bacterial loads within the thymus 
(Figure 2A) in mice infected with the highly virulent strain, in agreement with what has 
been described for other organs (21, 22). Histologically, increasing numbers of acid fast 
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bacilli were detected and progressive loss of the thymic structure was observed in 
samples taken from mice infected with the highly virulent strain but no significant 
alterations were found in thymi from mice infected with the low virulence strain up to 80 
dpi (Figure 2B). As previously shown, mice infected with the highly virulent strain 
developed peripheral lymphopenia which was not observed in the case of infection by 
strain 2447 (supplementary figure 1A). Removal of the thymus prior to infection with 
strain 25291 caused a slight increase in the peripheral depletion of T cells (supplementary 
figure 1B) suggesting that thymic atrophy may have minor additive effects on the 
development of peripheral lymphopenia. 
 
Thymic atrophy induced by M. avium infection is IFN-dependent and mediated by 
nitric oxide 
IFN is a key cytokine in the protective immune response against mycobacterial infection 
(31, 32) but has also been shown to participate in the induction of peripheral 
lymphopenia associated with M. avium 25291 infection (21, 22). To determine if 
IFNwas also implicated in M. avium infection thymic atrophy we analyzed the thymi of 
IFN knock-out (KO) mice during infection by strain 25291. As shown in Fig. 3A, mice 
that are unable to produce IFN exhibited no thymic atrophy despite having similar 
mycobacterial burdens (7.9±0.5 and 8.0±0.4 log10CFU/thymus in WT and IFN-KO 
mice, respectively, at 70 dpi). This observation shows that IFN is essential for thymic 
atrophy during M. avium 25291 infection. Although essential for the depletion of 
lymphocytes at the periphery IFN was shown not to act directly on T cells as the loss of 
these latter cells occurred in chimeric mice whose T cells lacked the receptor for IFN 
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(22). The most likely candidate for an IFN-responsive effector cell mediating 
lymphocyte or thymocyte loss is the macrophage. Thus, we infected “macrophage 
insensitive to IFN” (MIIG) mice, whose CD68-expressing cells (mostly macrophages) 
do not respond to IFN(27). In four independent experiments, control WT mice showed 
consistent thymic atrophy, ranging from 86 to 98% depletion of thymic cells during 
infection with strain 25291 whereas MIIG mice showed partial protection with 66% 
(p<0.05), 27% (not statistically significant, NSS), 29% (NSS), and 74% (NSS) depletion 
of thymic cells. Figure 3B shows the data of one of the experiments where sub-
populations were analysed and where no statistically significant differences were found. 
These data show that the macrophage is one of the cell types mediating thymocyte loss.  
One of the major consequences of the activation of macrophages by IFN is the increased 
production of nitric oxide due to the increased expression of the inducible (type 2) nitric 
oxide synthase (iNOS). To assess the possible role of this reactive species in the 
induction of thymic atrophy we infected iNOS-deficient animals with strain 25291. As 
shown in Figure 3C, iNOS-KO mice did not develop atrophy of the thymus. Interestingly 
the bacterial load within the thymus was almost the same between wild type and iNOS-
deficient mice (7.7 and 7.5 log10CFU/thymus in WT and iNOS-KO mice, respectively, at 
80 dpi). 
 
Glucocorticoids cooperate with nitric oxide in the induction of thymus atrophy  
As increased levels of glucocorticoids are widely recognized as a common cause for 
increased thymocyte apoptosis during infection (16-18) we questioned whether 
corticosteroids were necessary for M. avium-induced thymic atrophy. Mice infected with 
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strain 25291 but not those infected by strain 2447 showed slightly increased serum levels 
of corticosterone at 60 and 80 dpi (Figure 4A). The increase in corticosterone induced by 
the highly virulent strain of M. avium was observed both in control WT mice and in 
IFN-deficient mice showing that corticosteroids on their own were not sufficient to 
induce the atrophy of the thymus. To assess the biological role of this hormone in thymic 
atrophy, mice were infected with strain 25291 and treated daily with a steroid receptor 
type II antagonist (RU486) throughout the period of M. avium infection. In one 
experiment, the RU486 treatment of infected mice partially reverted the atrophy of the 
thymus whereas in the second experiment, such reversion was complete (Fig. 4B) as 
compared to vehicle-treated controls. No effect of RU486 on peripheral lymphopenia was 
observed in either experiment (data not shown). 
Given that corticosterone blood levels showed only minor increases between M. avium 
25291-infected and control non infected mice and that, in contrast, RU486 treatment was 
quite active in preventing thymic atrophy in infected animals we next investigated if 
thymocytes became more sensitive to apoptosis-inducing stimuli during infection by the 
highly virulent strain of M. avium. To that purpose, control and infected mice were 
administered with dexamethasone, known to induce extensive cell death via 
corticosteroid receptor activation (33). Since IFN-KO mice do not exhibit thymus 
atrophy, we compared the effects of dexamethasone in both IFN-KO and WT animals. 
Mice were given increasing doses of dexamethasone (0.1, 1.0 and 4.0 mg/Kg) 24 h before 
sacrifice at 50 dpi and compared to non-infected controls treated in a similar way. We 
observed a dose-dependent decrease of total and DP cells in both infected and non-
infected WT and IFN-KO mice (Fig. 4C and D). Thymocyte loss was exacerbated by 
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infection in WT mice but not in IFN-KO animals showing that IFN production during 
infection increases thymocyte susceptibility to dexamethasone-induced cell death. 
Impairment of the earliest stages of thymocyte development 
To further dissect at what levels of the thymocyte development the infection impacts on 
cell viability, we analysed in detail DN  thymocytes of mice infected with each M. avium 
strain. Whereas in mice infected with the low virulence strain no differences were 
observed in the DN1 to DN4 populations, animals infected with M. avium 25291 showed 
progressive reduction in cell numbers at all stages (Figure 5A and B). The relative 
reduction in all stages was similar such that the proportions remained almost unchanged 
(Figure 5A). We next analyzed what changes were found in M. avium 25291-infected 
mice that showed no thymic atrophy either because they were unable to produce IFN, 
their macrophages did not respond to IFN or they do not express iNOS. No major 
alterations were induced by infection in IFN-KO or MIIG mice that exhibited normal or 
only slightly reduced numbers of DN1 to DN4 subpopulations (Figure 5C and D). 
Likewise, iNOS-deficient mice also maintained most of these subpopulations unchanged 
during infection except for DN2 (Figure 5E). Finally, we analyzed the most immature 
thymocytes, the early thymic precursors (ETP), defined in the DN population as lineage-
negative, CD44
+
, CD25
-
 and c-Kit
+
 cells (see Supplementary figure 2 for a schematic 
representation of the gating strategy used to select this population). These cells were 
almost lost during infection of WT mice with the highly virulent strain of M. avium but 
not during infection with the strain 2447 (Figure 6A and B). No loss was found in IFN-
KO or MIIG mice infected with the highly virulent strain 25291 (Figure 6C to F) but a 
statistically significant reduction was found in iNOS-KO animals (Figure 6G and H). 
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Discussion 
We examined here the mechanisms underlying the emergence of progressive 
thymic atrophy in mice infected with M. avium 25291. We showed that IFN-deficient 
animals are resistant to the M. avium-induced thymic atrophy consistent with the fact that 
albeit essential for protective immunity against mycobacteria (31, 32) production of IFN 
by T cells may not always be correlated with protection during infection by HIV or M. 
tuberculosis (34-37). IFN has been shown to be involved in the development of 
peripheral lymphopenia in mice infected with M. avium 25291 (22), to limit the 
exacerbated T cell activation responsible for immune pathology associated with 
granulomatous lesions (38) and to increase apoptosis of DP thymocytes (39). 
Furthermore, IFN produced during measles virus infection not only inhibited cell 
proliferation but also disrupted the thymic epithelium responsible for thymocyte survival 
and differentiation into mature T cells, leading to thymic atrophy (40). Since IFN does 
not act directly on lymphocytes in the periphery to induce their demise (22), and 
macrophages accumulate in large numbers in tissue granulomas and in the thymus of M. 
avium-infected mice (23, 24) we assessed the involvement of these phagocytes in the 
IFN-mediated atrophy of the thymus. MIIG mice have macrophages (defined as CD68-
expressing cells) that do not respond to IFN and were found here not to develop thymic 
atrophy. This shows that macrophages respond to IFN and mediate to a great extent the 
involution of the organ. Since IFN-activated macrophages secrete important quantities 
of nitric oxide, we next evaluated the fate of the thymus in iNOS-deficient animals 
infected with strain 25291. These mice showed no evidence of thymic atrophy. Thus, a 
major pathway leading to thymic atrophy is dependent on the induction of iNOS 
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expression in macrophages by IFN produced in response to infection. Nitric oxide has 
already been shown to be important in limiting T cell activity and survival at the 
periphery during mycobacterial infections (38) but this is the first demonstration of its 
activity in the thymus of an infected animal. 
The mycobacterial loads in the thymus of mice infected with strain 25291 were 
significantly higher than those of mice infected with strain 2447 raising the possibility 
that the mycobacteria might themselves be toxic for the thymic tissue. However, this is 
not supported by the fact that the bacterial loads in the thymi of infected WT mice which 
undergo atrophy were very similar to those found in IFN- or iNOS-deficient animals 
which did not develop such atrophy. Moreover, M. avium is known to be relatively non-
toxic as evidenced by the very high microbial burdens that can be observed in infected 
hosts and which are still compatible with their survival (41-43). 
The most frequent mechanism implicated in infection induced thymic atrophy is 
increased thymocyte apoptosis due to increased production of GCs (15-17, 44-46). For 
example, the severe thymic atrophy found in mice infected with Trypanosoma cruzi is 
caused by an increased production of GCs (17, 47). This can also be seen during M. 
tuberculosis infection (48) or in mice given an injection of M. tuberculosis cord factor 
(trehalose 6,6’-dimycolate) (49). The activity of GCs might also synergize with that of 
IFN. IFN is known to increase serum levels of TNF which in turn induces thymocyte 
apoptosis and augments the susceptibility of thymocytes to GCs (50). Given the 
importance of GCs in thymic involution, we studied whether GCs were implicated in the 
depletion of thymocytes during M. avium infection. Indeed, the infection with the highly 
virulent strain led to an increase, albeit small, of serum corticosterone levels. To 
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determine if this increase affected thymocyte numbers we performed an in vivo functional 
assay, using an antagonist of the GC receptor (RU486). In two independent experiments 
RU486 partially or completely reversed M. avium-induced thymus atrophy. Furthermore, 
infection increased thymocyte depletion by dexamethasone with cells from WT animals 
being more susceptible than those of IFN-deficient mice. These data show an increase in 
susceptibility to GC-mediated thymocyte elimination. Although it is unclear to what 
extent GCs are required for M. avium-induced thymic atrophy we suggest that they do 
play at least a partial role. It is clear, however, that GCs on their own are not sufficient to 
induce M. avium-induced thymic atrophy and that they need to synergize with IFN or 
IFN-induced pathways. The source of the GCs that participate in thymic involution is 
unclear. It has been shown that the murine thymus itself is capable of producing GCs (52) 
and it was suggested that thymic epithelial cells may be able to produce GCs that would 
act directly in thymocytes (53, 54). The mechanisms that underlie the IFN dependence 
to GC sensitivity are also not known, although changes in the levels of Notch and Bcl-2 
expression have been suggested (55). Further work is needed to clarify this issue. 
Since thymocytes expand several orders of magnitude from incoming bone 
marrow-derived precursors, a reduction in early thymic precursors could impact on 
thymic cellularity. The progressive reduction in thymocyte numbers observed here was 
seen among the DN1 to the DN4 stages to an extent which was proportional to the 
relative abundance of these cells in a normal thymus. Furthermore, the most immature 
thymocytes (c-Kit
+
, lin
-
 DN1 cells) were found to be severely deficient in advanced 
stages of thymic atrophy. These observations are consistent with several scenarios of 
thymocyte depletion: 1) it might occur predominantly in the thymus and affect all cell 
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types, 2) there might be a predominant effect on the recently arrived precursors impacting 
on the subsequent ability to expand inside the thymic tissue or, 3) a reduction in the 
release of precursors from the bone marrow might reduce thymus seeding. In this context, 
it has been shown that early lymphoid progenitors in mouse and man are highly sensitive 
to GCs (56) and alterations in chemokine expression and bone marrow retention 
phenomena are observed in HIV infected patients (57). Our data with iNOS-deficient 
mice suggest that at least some of the reduction in thymocyte numbers is occurring 
locally in the thymus. iNOS-deficient mice showed a statistically significant reduction in 
the number of early thymocyte precursors suggesting that nitric oxide-independent 
mechanisms lead to the failure of the bone marrow to seed the thymus. Yet, despite the 
reduced seeding of the thymus by early thymocyte precursors iNOS-deficient animals did 
not develop thymic atrophy indicating that nitric oxide may be required for local 
thymocyte death in the thymic tissue. The lower production of thymic precursors by the 
bone marrow might be due to the direct action of IFN on haematopoietic stem cells or 
multipotent progenitors as has already been proposed (58-60). The fact that MIIG mice 
are not as well protected from thymocyte loss as IFN-deficient mice suggests that IFN 
may also act on cells other than the macrophage, namely the progenitor cells in the bone 
marrow. Although thymic emigrants are important for the maintenance of the peripheral 
lymphocyte pool (61-63) and the loss of thymic output may accelerate the loss of splenic 
T cells, as shown here in thymectomized mice (supplementary figure 1B) we found that 
peripheral lymphopenia still occurs in situations where the thymus remains apparently 
intact such as in iNOS-deficient animals or when GC activity has been blocked by the 
receptor antagonist RU486 (data not shown). 
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In summary, the present report identifies the role of IFN-activated macrophages 
and their ability to produce nitric oxide in the development of thymic atrophy most likely 
co-adjuvanted by the increased susceptibility to GC-mediated thymocyte apoptosis that 
develops during infection with the highly virulent strain of M. avium and suggest the 
possibility of a failure of the bone marrow to seed the thymus with precursors. 
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Figure Legends 
 
Figure 1: Infection with the highly virulent M. avium strain 25291 but not with the low 
virulence strain 2447 induces strong thymus atrophy. 
A. Photographs of thymi from uninfected WT mice (Ninf) and WT mice infected with M. 
avium strains 2447 or 25291 at the indicated time-points (in days post-infection, dpi). B, 
C. Thymus weight and number of thymocytes from control non-infected (Ninf) mice and 
animals infected with strains 2447 or 25291. D. Representative plots of anti-CD4 and 
anti-CD8 staining of thymi from control non-infected (Ninf) mice and mice infected with 
strains 2447 or 25291. The numbers indicate the percentage of cells in each region. E, F. 
Percentage and number of thymic populations from control non-infected (Ninf) mice and 
animals infected with strains 2447 or 25291. Data represent the mean of the percentages 
or the mean and standard deviation of the numbers of cells. Each group of non-infected 
mice comprised three to four animals and each group of infected mice comprised seven 
animals analysed individually and data presented represents one experiment out of three. 
Statistically significant differences between infected and non-infected (Ninf) mice are 
labeled as *p0.05, **p0.01, ***p0.001. Statistically significant differences between 
infected groups are labeled as ###p<0.001. 
 
Figure 2: Infection with M. avium strain 25291 leads to higher bacterial loads in the 
thymus as compared with strain 2447. 
A. Representative kinetics of M. avium infection of the thymus from WT mice inoculated 
with strains 2447 or 25291. Data represent the mean and standard deviation of CFU from 
five mice per group from one out of three experiments. Statistically significant 
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differences between mice infected with strains 2447 and 25291 are labeled as *p0.05, 
**p0.01, *** p0.001. B. Representative thymic sections from non-infected mice (Ninf) 
and mice infected with strains 2447 or 25291 stained for acid-fast bacteria (Ziehl-Neelsen 
method). Scale bars represent 200 µm in the low-power views and 20 µm in the high 
magnification pictures. Arrowheads indicate acid fast bacteria in cases of low infection 
burden. 
 
Figure 3: Thymus atrophy depends on IFN production, IFN-dependent macrophage 
activation and nitric oxide production.  
A. Number of cells of the thymic populations from WT or IFN-KO mice, either non-
infected (Ninf) or infected with M. avium 25291 at 75 dpi. B. Number of cells of the 
thymic populations from WT or MIIG transgenic mice, either non-infected (Ninf) or 
infected with M. avium 25291 at 80 dpi. C. Number of cells of the thymic populations 
from WT or iNOS-KO mice, either non-infected (Ninf) or infected with M. avium 25291 
at 80 dpi. Data represent the mean and standard deviation of the numbers of cells. Each 
group of mice comprised three to seven animals analyzed individually. Data shown 
represents one out of three experiments. Statistically significant differences between 
infected and non-infected  mice are labeled as **p0.01, ***p0.001. Statistically 
significant differences between infected groups are labeled as #p0.05, ##p0.01, 
###p0.001. 
 
Figure 4: Glucocorticoids are involved in the induction of thymus atrophy during 
infection with M. avium strain 25291.  
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A. Representative kinetics of serum corticosterone levels in WT mice infected with M. 
avium 25291 or 2447 as compared to non-infected (Ninf) mice or of IFN-KO mice 
infected with strain 25291 versus non-infected (Ninf). B. Number of thymocytes from 
non-infected (Ninf) mice and mice infected for 75 days with M. avium 25291 and treated 
with either vehicle or RU486 (RU). Data represent the mean and standard deviation of 
values obtained from six to eight mice in each group analyzed individually and represents 
two independent experiments. Statistically significant differences between infected and 
non-infected mice are labeled as *p 0.05, **p <0.01 ***p 0.001. C, D. Decrease of 
total (C) and DP (D) thymocytes after dexamethasone treatment of non-infected (Ninf) or 
M. avium 25291-infected animals of either WT or IFN-KO strains. Data represent the 
ratio between the cell numbers in dexamethasone-treated animals and the cell numbers in 
PBS-treated animals, i.e. the fraction of cells remaining after dexamethasone treatment. 
 
Figure 5: Infection with M. avium strain 25291 induces depletion of all subpopulations 
of DN thymocytes which depends on IFN production, IFN-dependent macrophage 
activation and NO production. 
A, B. Percentage and number of DN thymic subpopulations from non-infected (Ninf) 
mice and mice infected with strains 2447 or 25291. C. Number of DN thymic 
subpopulations from WT and IFN-KO mice, either non-infected (Ninf) or infected with 
M. avium 25291 at 80 dpi. D. Number of DN thymic subpopulations from WT and MIIG 
mice, either non-infected (Ninf) or infected with M. avium 25291 at 80 dpi. E. Number of 
DN thymic subpopulations from WT and iNOS-KO mice, either non-infected (Ninf) or 
infected with M. avium 25291 at 80 dpi. Data represent the mean and standard deviation 
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of the number of cells. Each group of mice comprised three to six animals analyzed 
individually. Data shown represents one experiment out of three. Statistically significant 
differences between infected and control mice are labeled as *p0.05, **p0.01, 
***p0.001. Statistically significant differences between infected groups are labeled as 
#p0.05, ##p0.01, ###p0.001. 
 
Figure 6: Infection with M. avium 25291 induces depletion of the early thymocyte 
precursors and depends on IFN production, IFN-dependent macrophage activation and 
NO production. 
 A, B. Percentage (A) and number (B) of ETP from non-infected (Ninf) thymi and from 
thymi of WT mice infected with M. avium strains 2447 or 25291. C, D. Percentage (C) 
and number (D) of ETP from non-infected (Ninf) thymi and from thymi of WT or IFN-
KO mice infected with M. avium 25291 at 80 dpi. E, F. Percentage (E) and number (F) of 
ETP from non-infected (Ninf) thymi and from thymi of WT or MIIG mice infected with 
M. avium 25291 at 80 dpi. G, H. Percentage (G) and number (H) of ETP from non-
infected (Ninf) thymi and from thymi of WT or iNOS-KO mice infected with M. avium 
25291 at 80 dpi. Data represent the mean of the percentages or the mean and standard 
deviation of the number of cells. Each group of mice comprised three to six animals 
analysed individually. Data shown represents one experiment out of three. Statistically 
significant differences between infected and non-infected control mice are labeled as 
*p0.05, **p0.01, ***p0.001. Statistically significant differences between infected 
groups are labeled as #p0.05, ##p0.01, ###p<0.001. 
 
